Fairmount Funds Management LLC
Position in COGT — Cogent Biosciences, Inc.
CIK 1802528
WEST CONSHOHOCKEN, PA
Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$212,982,276
+$1,155,718 QoQ
Shares Held
5,503,418
0.0% QoQ
Ownership
3.17%
of shares outstanding
% of Portfolio
14.08%
of 13F equity value
Holder Rank
#7
of 321 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fairmount Funds Management LLC holds $1,512,967,792 across 12 Biotechnology names. COGT ranks #4 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
3,705,262 | $352,629,784 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,537,191 | $247,325,378 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
|
8,713,000 | $226,625,130 | |
| 4 | COGT |
Cogent Biosciences, Inc.
This page
|
5,503,418 | $212,982,276 | |
| 5 | JBIO |
Jade Biosciences, Inc.
|
4,553,494 | $101,178,636 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
1,855,644 | $94,173,933 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
5,090,928 | $93,520,347 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
2,359,025 | $59,872,054 |
All Filings in COGT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,982,276 | 5,503,418 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $211,826,558 | 5,503,418 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $319,801,407 | 9,003,418 | Shares | Sole | 2026-02-17 | |
| 2025-11-13 | $537,133,050 | 15,877,418 | Shares | Sole | 2025-11-17 | |
| 2025-09-30 | $129,289,082 | 9,003,418 | Shares | Sole | 2025-11-14 | |
| 2025-07-10 | $155,425,360 | 14,324,918 | Shares | Sole | 2025-07-14 | |
| 2025-06-30 | $44,700,102 | 6,225,641 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $37,291,589 | 6,225,641 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $48,559,999 | 6,225,641 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $67,236,922 | 6,225,641 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $52,482,153 | 6,225,641 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $31,756,307 | 4,725,641 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,926,773 | 3,558,975 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $34,700,006 | 3,558,975 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,138,264 | 3,558,975 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $29,769,340 | 2,758,975 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,893,751 | 2,758,975 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $41,163,907 | 2,758,975 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $24,885,954 | 2,758,975 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,676,722 | 1,558,975 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,376,005 | 1,558,975 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,110,979 | 1,558,975 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,643,287 | 1,558,975 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $13,687,800 | 1,558,975 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,507,289 | 1,558,975 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 UMRX | — | 6,235,903 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||